Measuring global biotechnology innovation
The Scientific American WorldView project, where I’ve been serving as lead editorial consultant, is ramping up for its May 20th launch at BIO 2009. One of the objectives for the project was to put marketing-speak aside and objectively measure biotechnology innovation progress around the world. Going beyond gross regional measures, we compare individual countries to distill best practices, opportunities for growth, and uncover hidden gems.
Intrigued? You can hear me talk more about it on BIO’s BIOtech Now blog, and the full publication will be available at BIO 2009 in Atlanta.
Hello as a drug development consultant I must admit that I do see a great deal of me too innovation, but as a specialist in emerging companies I see more than my fair share of true innovation steming from blue sky research, as a result I am always left feeling that I work in a highly innovative industry, but I wonder if others see this side of it.
Being able to accurately measure biotech innovation will be difficult at best, but the results will be interesting.
I would love to see a comparison between innovation before and after the billions thrown at the NIH to help stimulate the economy. ie Was the money well spent or does just throwing government money at a problem turn out to be a waste of resources.
I don’t have a particular opinion, but would be interested in the results.